The Cloning Protein Production, Crystallization, and X-ray Data Collection Core
克隆蛋白生产、结晶和 X 射线数据收集核心
基本信息
- 批准号:7063034
- 负责人:
- 金额:$ 90.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-09-01 至 2011-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The Cloning, Protein Production, Crystallization, and X-ray Data Collection Core constitute a distributed
pipeline for X-ray crystal structure determination. The distributed structure takes advantage of local
expertise, with the cloning facility at Texas A&M University, the protein purification facility at Los Alamos
National Labs, the crystallization facility at Lawrence Livermore National Laboratory, the nanocrystallization
facility at UC Berkeley and the X-ray data collection and analysis core located at the Advanced Light Source.
This core group is responsible for the majority of the cloning, purification, crystallization and data collection
with the program project. The overall goal of this group of core laboratories is to: 1) provide a rapid access
library of expressible clones for structural, biochemical and genetic studies, 2) provide highly purified target
proteins with sufficient quantity for structure determination through standardization, automation, and
parallelization of protocols 3) conduct crystal screens for crystal studies 4) provide screening solutions for
inhibitor screens, 5) collect high-resolution MAD data to solve 30-40 structures per year.
The pipeline facilities are capable of conducting large-scale clone preparation using a modified Gateway
cloning system (Invitrogen) that incorporates a cleavable fusion tag into the system and allows for
expression in both E. coli and M. smegmatis. The protein production facility has the capacity to produce 6-8
highly purified target proteins per week using high yield auto-inducing fermentation, parallel cell lysis, parallel
affinity and gel filtration chromatography. The crystallization facility currently has the peak capability to
prepare 3000 crystallization experiments daily, which is sufficient to screen 8 proteins per day. Some high
value targets cannot be produced in quantities sufficient for standard processing and will be screened for
crystallization at the UCB nanocrystallization facility. The UCB nano-crystallization facility has developed the
infrastructure to screen 384 conditions each for as many as 100 proteins annually using the Fluidigm
screening chips. The screening chip requires <2uL of protein per 96 experiments. The X-ray facility has 2
days per month pre-scheduled beam time at the Advanced Light Source (ALS). This time is sufficient to
screen crystals and collect MAD data for the determination of up to 30-40 de novo structures per year. The
core labs described in this proposal are essential for the successful completion of the overall goals of this
program project.
克隆、蛋白生产、结晶、x射线数据采集核心构成了一个分布式系统
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES C SACCHETTINI其他文献
JAMES C SACCHETTINI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES C SACCHETTINI', 18)}}的其他基金
Structure-based Discovery of Critical Vulnerabilities of Micobacteria
基于结构的微生物关键漏洞发现
- 批准号:
8711232 - 财政年份:2012
- 资助金额:
$ 90.72万 - 项目类别:
Structure-based Discovery of Critical Vulnerabilities of Micobacteria
基于结构的微生物关键漏洞发现
- 批准号:
8534693 - 财政年份:2012
- 资助金额:
$ 90.72万 - 项目类别:
Structure-based Discovery of Critical Vulnerabilities of Mycobacteria
基于结构的分枝杆菌关键漏洞发现
- 批准号:
9755323 - 财政年份:2012
- 资助金额:
$ 90.72万 - 项目类别:
Structure-based Discovery of Critical Vulnerabilities of Mycobacteria
基于结构的分枝杆菌关键漏洞发现
- 批准号:
10242858 - 财政年份:2012
- 资助金额:
$ 90.72万 - 项目类别:
Structure-based Discovery of Critical Vulnerabilities of Mycobacteria
基于结构的分枝杆菌关键漏洞发现
- 批准号:
10456888 - 财政年份:2012
- 资助金额:
$ 90.72万 - 项目类别:
相似国自然基金
鲜驴乳中游离脂肪酸对Mycobacterium tuberculosis H37Rv活性的影响及机制研究
- 批准号:31760442
- 批准年份:2017
- 资助金额:38.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Fragment to small molecule hit discovery targeting Mycobacterium tuberculosis FtsZ
针对结核分枝杆菌 FtsZ 的小分子片段发现
- 批准号:
MR/Z503757/1 - 财政年份:2024
- 资助金额:
$ 90.72万 - 项目类别:
Research Grant
Functional exploration of a deep Mycobacterium tuberculosis phosphoproteome
结核分枝杆菌深层磷酸蛋白质组的功能探索
- 批准号:
10656957 - 财政年份:2023
- 资助金额:
$ 90.72万 - 项目类别:
The role of the gut microbiome in susceptibility to Mycobacterium tuberculosis
肠道微生物组在结核分枝杆菌易感性中的作用
- 批准号:
10647554 - 财政年份:2023
- 资助金额:
$ 90.72万 - 项目类别:
Optimizing Multi-drug Mycobacterium tuberculosis Therapy for Rapid Sterilization and Resistance Suppression
优化结核分枝杆菌多药治疗以实现快速灭菌和耐药性抑制
- 批准号:
10567327 - 财政年份:2023
- 资助金额:
$ 90.72万 - 项目类别:
Analysis of essentiality of thymidylate synthase and methionine adenosyltransferase in Mycobacterium tuberculosis
结核分枝杆菌胸苷酸合酶和甲硫氨酸腺苷转移酶的必要性分析
- 批准号:
23K14522 - 财政年份:2023
- 资助金额:
$ 90.72万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Structural characterization of MCE transport systems from Mycobacterium tuberculosis
结核分枝杆菌 MCE 转运系统的结构表征
- 批准号:
10681871 - 财政年份:2023
- 资助金额:
$ 90.72万 - 项目类别:
Impact of Mycobacterium tuberculosis on monocyte differentiation in vivo
结核分枝杆菌对体内单核细胞分化的影响
- 批准号:
10606380 - 财政年份:2023
- 资助金额:
$ 90.72万 - 项目类别:
Elucidation of factors affecting environmental persistence of non-tuberculous Mycobacterium tuberculosis and related genomic factors
影响非结核分枝杆菌环境持久性的因素及相关基因组因素的阐明
- 批准号:
23H00451 - 财政年份:2023
- 资助金额:
$ 90.72万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Structural basis for the induction of dormancy in Mycobacterium tuberculosis
结核分枝杆菌休眠诱导的结构基础
- 批准号:
23H02417 - 财政年份:2023
- 资助金额:
$ 90.72万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
SIGMA: Small molecule Inhibitors targeting the Genetic determinants of Mutagenesis and Adaptability in Mycobacterium tuberculosis
SIGMA:针对结核分枝杆菌突变和适应性的遗传决定因素的小分子抑制剂
- 批准号:
EP/X032817/1 - 财政年份:2023
- 资助金额:
$ 90.72万 - 项目类别:
Research Grant